Results 131 to 140 of about 387,299 (303)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2010
The aim of review. To cite the literature data, confirming efficacy of ursodeoxycholic acid (UDCA) at alcoholic and non-alcoholic steatohepatitis (NASH).Original positions.
Ye. A. Fedos’ina, M. V. Mayevskaya
doaj  

Alcoholic liver disease. An update

Annals of Hepatology, 2005
The prevalence and incidence of alcoholic liver disease are constantly evolving. Alcoholic liver disease has a wide clinical spectrum. It may progress to cirrhosis and to end-stage liver disease requiring liver transplantation.
Nahum Méndez-Sánchez, Paloma Almeda-Valdés, Misael Uribe   +2 more
doaj   +1 more source

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

Journal of Translational Medicine, 2008
Background Inside the spectrum of non-alcoholic fatty liver disease, simple fatty liver is generally thought of as being "non progressive", differently from non-alcoholic steatohepatitis, which increases in severity due to the presence of apoptosis ...
Contaldo Franco, Pasanisi Fabrizio, Chianese Domenico, Di Minno Matteo N, Tarantino Marianna, Riccio Antonio, Conca Paolo, Tarantino Giovanni, Scopacasa Francesco, Capone Domenico   +9 more
doaj   +1 more source

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.

Gastroenterology, 2019
BACKGROUND & AIMS We studied the role of interleukin 11 (IL11) signaling in the pathogenesis of nonalcoholic steatohepatitis using hepatic stellate cells (HSCs), hepatocytes, and mouse models of non-alcoholic steatohepatitis (NASH).
A. Widjaja, B. Singh, E. Adami, S. Viswanathan, Jin-Rui Dong, Giuseppe D'Agostino, B. Ng, Wei-Wen Lim, Jessie Tan, B. Paleja, M. Tripathi, Sze-Yun Lim, Shamini G Shekeran, S. Chothani, Anne Rabes, M. Sombetzki, E. Bruinstroop, L. Min, R. Sinha, S. Albani, P. Yen, S. Schafer, S. Cook   +22 more
semanticscholar   +1 more source

Comprehensive treatment of patients with type 2 diabetes, complicated by diabetic kidney disease, with concomitant non-alcoholic steatohepatitis

Mìžnarodnij Endokrinologìčnij Žurnal
Background. The purpose of research is to establish the effect of bicyclol on the clinical manifestations of non-alcoholic steatohepatitis (NASH), markers of liver damage in patients with non-alcoholic steatohepatitis, and diabetes mellitus type 2 (DM2),
Z.Ya. Kotsiubiichuk, А.А. Antoniv, O.V. Kaushanska, L.V. Kanovska, Yu.M. Yarinich   +4 more
doaj   +1 more source

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis [PDF]

, 2007
Non-alcoholic fatty liver disease comprises a spectrum of diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, and cirrhosis.
LIRUSSI, FLAVIO, ORLANDO, ROCCO, MASTROPASQUA E, ORANDO S   +3 more
core  

Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.

Journal of Hepatology, 2019
BACKGROUND & AIMS Non-invasive tools for monitoring treatment response and disease progression in non-alcoholic steatohepatitis (NASH) are needed. Our objective was to evaluate the utility of magnetic resonance (MR)-based hepatic imaging measures for the
S. Jayakumar, M. Middleton, E. Lawitz, P. Mantry, S. Caldwell, Hays L. Arnold, Anna Mae Diehl, R. Ghalib, M. Elkhashab, M. Abdelmalek, K. Kowdley, C. Stephen Djedjos, Ren Xu, Ling Han, G. Subramanian, R. Myers, Z. Goodman, N. Afdhal, M. Charlton, C. Sirlin, R. Loomba   +20 more
semanticscholar   +1 more source

Non-alcoholic steatohepatitis and liver transplantation

, 2016
Non-alcoholic steatohepatitis is a growing liver-related health problem. In Europe, non-alcoholic fatty liver disease is the most usual reason of chronic liver illness while steatohepatitis, its progressive form, affects 1% of Europeans and North ...
Andreone, Pietro, Pirillo, Martina, VILLA, Erica, Gitto, Stefano, Vitale, Giovanni, Vukotic, Ranka   +5 more
core   +1 more source

Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis

Cell Metabolism, 2019
SUMMARY Oxidized phospholipids (OxPLs), which arise due to oxidative stress, are pro-inflammatory and pro-atherogenic, but their roles in non-alcoholic steatohepatitis (NASH) are unknown. Here, we show that OxPLs accumulate in human and mouse NASH. Using
Xiao-Li Sun, J. Seidman, Peng Zhao, T. Troutman, N. Spann, Xu-Chu Que, Fangli Zhou, Z. Liao, Martina P. Pasillas, Xiao-Hong Yang, Jason Magida, T. Kisseleva, D. Brenner, M. Downes, R. Evans, A. Saltiel, S. Tsimikas, C. Glass, J. Witztum   +18 more
semanticscholar   +1 more source

Is non-alcoholic steatohepatitis caused by alcohol?

, 2020
Obesity and the associated diseases such as the metabolic syndrome, hypertryglyceridemia and diabetes mellitus type 2 are the most frequent causes of Non-Alcoholic Fatty Liver Diseases (NAFLD) [1-5].
Hubert E Blum, Blum Hubert E, Hubert E, Blum   +2 more
core   +1 more source